Stratum Dx performs Direct Immunofluorescence (DIF) in-house, allowing for faster turnaround times and tighter clinicopathologic correlation. DIF plays a critical role in the evaluation of autoimmune blistering diseases, vasculitides, and connective tissue disorders.
By keeping DIF testing in-house, our dermatopathologists directly correlate histology, immunofluorescence findings, and clinical information—improving diagnostic accuracy and efficiency.
Direct immunofluorescence is most often requested when clinical or histologic findings raise concern for immune-mediated dermatologic disease. Common indications include evaluation of the following conditions:
Autoimmune Blistering Diseases
Vasculitis and Immune Complex–Mediated Disease
Connective Tissue Disease
Additional Immune-Mediated Conditions
Stratum Dx is CLIA-certified and hospital-level CAP-accredited, meeting standards that exceed CMS regulatory requirements. CAP accreditation reflects our commitment to rigorous quality assurance, diagnostic accuracy, and operational excellence—and supports broad insurance acceptance for patient convenience.
